Cevian Capital Boosts Smith & Nephew (SN.) Stake to 14.21% After August 2026 Acquisition

Cevian Capital Boosts Smith & Nephew (SN.) Stake to 14.21% After August 2026 Acquisition →

Cevian Capital II GP Limited has raised its total voting rights in Smith & Nephew plc (SN.), the London-listed global medical technology firm, to 14.214414% as of 7 August 2026, up from 14.010786% reported in a prior notification dated 24 J…